Yahoo Finance

Gradient Denervation Technologies Enrolls Initial Patient in First-In-Human Study of Pulmonary Artery Denervation Technology

PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients ...
Yahoo Finance

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based catheter system designed to treat ...
Business Wire

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

PARIS--(BUSINESS WIRE)--Gradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces ...
manilatimes

Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company's pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and ...
Finanznachrichten

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

Serial entrepreneur and medical device industry executive adds key experience to board of directors PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical ...
PharmiWeb

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

Thuja Capital and founding investor Sofinnova Partners also joined the round The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based ...